UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013604
Receipt number R000015891
Scientific Title The crossover study using insulin degludec in basal-bouls insulin therapy of childhood type 1 diabetes
Date of disclosure of the study information 2014/04/02
Last modified on 2014/04/02 07:14:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The crossover study using insulin degludec in basal-bouls insulin therapy of childhood type 1 diabetes

Acronym

JT1DDG

Scientific Title

The crossover study using insulin degludec in basal-bouls insulin therapy of childhood type 1 diabetes

Scientific Title:Acronym

JT1DDG

Region

Japan


Condition

Condition

type 1 diabetes

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of insulin degludec in the basal bolus insulin insulin therapy of childhood type 1 diabetic patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of HbA1c level

Key secondary outcomes

Record of self glucose monitoring
Frequency of sever hypoglycemia


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The long-acting insulin will be switched to insulin degludec. 12wk later, the basal insulin will be returned to the former insulin.

Interventions/Control_2

The subjects use the same long acting insulin. 12wk later, the long-acting insulin will be switched to insulin degludec.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Type 1 diabetes with Basal-Bolus therapy
more than 1 year,
using insulin glargine or insulin detemir as the basal insulin,
and using rapid acting insulin as bolus insulin.
2)at least 3 times per day of (self-monitoring of blood glucose
3) Regular visiting to clinic
5)HbA1c < 10%

Key exclusion criteria

1)patients with sever diabetes complication. (Proliferating retinopathy or renal dysfunction: serum Cre > 2.0 mg/dl).
4)judged as ineligible by clinical investigators

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomoyuki Kawamura

Organization

Osaka City University Graduate School of Medicine

Division name

Department of Pediatrics

Zip code


Address

1-5-7, Asahi-machi, Abeno-ku, Osaka, Japan

TEL

06-6645-3816

Email

kawam@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoyuki Kawamura

Organization

Osaka City Graduate School of Medicine

Division name

Department of Pediatrics

Zip code


Address

1-5-7, Asahi-machi, Abeno-ku, Osaka, Japan

TEL

06-6645-3816

Homepage URL


Email

kawam@med.osaka-cu.ac.jp


Sponsor or person

Institute

Department of Pediatrics, Osaka City Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Pediatrics, Osaka City Graduate School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 04 Month 02 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 02 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 02 Day

Last modified on

2014 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015891


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name